As part of the Generation Equality Forum convened by UN Women and co-hosted by the governments of Mexico and France, the Bill & Melinda Gates Foundation today announced a commitment of $2.1 billion over the next five years to advance women’s economic empowerment, strengthen women and girls’ health and family planning, and accelerate women’s leadership. The forum takes place in Paris from June 30 to July 2, 2021, bringing together governments, the…
Women’s health startup Mammogen has announced the closing of its $2M seed round. The round was oversubscribed by a diverse group of high-net-worth investors, comprising 52% women, members of the LGBTQ+ community, and veterans from the US Armed Forces, according to the company. “The vast diversity across our investor base is evidence that the world is ready for a truly differentiated women’s health narrative,”…
Scientists from The Feinstein Institutes for Medical Research have announced the publication of results from a phase 3 clinical trial looking at the safety and efficacy of the oral neuroactive steroid zuranolone (30mg) in the treatment of patients with postpartum depression (PPD). The findings published in the Journal of the American Medical Association (JAMA) Psychiatry showed that after two weeks of daily treatment, women treated…
Maven, the leading virtual clinic for women’s and family health, today announced that it has hired Dr. Neel Shah, MD, MPP, FACOG, as Chief Medical Officer. A globally recognized expert in designing solutions that improve health care, Dr. Shah brings deep experience as a physician, professor and social entrepreneur to Maven. “Joining Maven presents a unique opportunity for me to build the…
The World Health Organization (WHO), the United Nations Special Programme HRP and the United Nations University International Institute for Global Health (UNU-IIGH) in partnership with the British Medical Journal (BMJ), have today released a special series of papers on “Women’s Health and Gender Inequalities.” The series celebrates and interrogates collective progress towards making the 1995 Beijing Declaration and Platform for Action on Women a reality…
Daré Bioscience has announced positive topline results from its Phase 1 clinical trial of DARE-HRT1. DARE-HRT1 is a novel IVR designed to deliver bio-identical 17β-estradiol and bio-identical progesterone continuously over a 28-day period as part of a hormone therapy (HT) regimen to treat the vasomotor symptoms (VMS) and genitourinary syndrome associated with menopause. The topline data from the study support DARE-HRT1’s potential to…
AOA Dx earlier today announced that they have been accepted to Y Combinator’s 2021 summer cohort and have closed a $2.5 million seed round to develop AKRIVIS GD, a liquid biopsy test that is set to revolutionize the future of ovarian cancer diagnostics. AOA Dx has been working in close collaboration with world renowned cancer researcher Professor H. Uri Saragovi, Senior Investigator…
Life Whisperer, fertility arm of AI healthcare company Presagen, will invite clinics to participate in its third global IVF clinic collaboration at the 37th European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting. The AI Open Project aims to apply AI to the assessment of oocytes, or female eggs prior to fertilization or freezing. Oocyte evaluation will be Life Whisperer’s third…
